Association of nine-fold change in UBE2C mRNA level (MC/non-MC lesions) and pathologic and clinical features.

aReceiver-operating characteristic curve determined nine-fold induction of UBE2C mRNA level as the cut-off showing 52.9% sensitivity and 66.7% specificity.bTwo-sided P-value by Fisher exact test.cPatients with malignant breast cancer.dTumor size typing of IDC.

a. 以UBE2C mRNA水平9倍升高作为截断值的受试者工作特征（Receiver-operating characteristic, ROC）曲线，其灵敏度为52.9%，特异度为66.7%。
b. 费希尔精确检验所得的双侧P值。
c. 乳腺恶性肿瘤患者。
d. 浸润性导管癌（Invasive Ductal Carcinoma, IDC）的肿瘤大小分型。